Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?
- PMID: 19723038
- PMCID: PMC3141289
- DOI: 10.1111/j.1749-6632.2009.04911.x
Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?
Abstract
Signal transducer and activator of transcription-3 (STAT-3) is one of six members of a family of transcription factors. It was discovered almost 15 years ago as an acute-phase response factor. This factor has now been associated with inflammation, cellular transformation, survival, proliferation, invasion, angiogenesis, and metastasis of cancer. Various types of carcinogens, radiation, viruses, growth factors, oncogenes, and inflammatory cytokines have been found to activate STAT-3. STAT-3 is constitutively active in most tumor cells but not in normal cells. Phosphorylation of STAT-3 at tyrosine 705 leads to its dimerization, nuclear translocation, DNA binding, and gene transcription. The phosphorylation of STAT-3 at serine 727 may regulate its activity negatively or positively. STAT-3 regulates the expression of genes that mediate survival (survivin, bcl-xl, mcl-1, cellular FLICE-like inhibitory protein), proliferation (c-fos, c-myc, cyclin D1), invasion (matrix metalloproteinase-2), and angiogenesis (vascular endothelial growth factor). STAT-3 activation has also been associated with both chemoresistance and radioresistance. STAT-3 mediates these effects through its collaboration with various other transcription factors, including nuclear factor-kappaB, hypoxia-inducible factor-1, and peroxisome proliferator activated receptor-gamma. Because of its critical role in tumorigenesis, inhibitors of this factor's activation are being sought for both prevention and therapy of cancer. This has led to identification of small peptides, oligonucleotides, and small molecules as potential STAT-3 inhibitors. Several of these small molecules are chemopreventive agents derived from plants. This review discusses the intimate relationship between STAT-3, inflammation, and cancer in more detail.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.Clin Cancer Res. 2009 Jan 15;15(2):425-30. doi: 10.1158/1078-0432.CCR-08-0149. Clin Cancer Res. 2009. PMID: 19147746 Review.
-
Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1.Mol Pharmacol. 2009 Mar;75(3):525-33. doi: 10.1124/mol.108.052548. Epub 2008 Dec 22. Mol Pharmacol. 2009. PMID: 19103760 Free PMC article.
-
Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.Ann N Y Acad Sci. 2006 Dec;1091:151-69. doi: 10.1196/annals.1378.063. Ann N Y Acad Sci. 2006. PMID: 17341611 Review.
-
STAT proteins as novel targets for cancer drug discovery.Expert Opin Ther Targets. 2004 Oct;8(5):409-22. doi: 10.1517/14728222.8.5.409. Expert Opin Ther Targets. 2004. PMID: 15469392 Review.
-
Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.Am J Pathol. 2003 May;162(5):1449-61. doi: 10.1016/S0002-9440(10)64278-2. Am J Pathol. 2003. PMID: 12707028 Free PMC article.
Cited by
-
Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development.Front Genet. 2023 Nov 29;14:1297093. doi: 10.3389/fgene.2023.1297093. eCollection 2023. Front Genet. 2023. PMID: 38094755 Free PMC article. Review.
-
Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer.Cancer Cell Int. 2023 Dec 12;23(1):320. doi: 10.1186/s12935-023-03174-4. Cancer Cell Int. 2023. PMID: 38087345 Free PMC article. Review.
-
Short Survey on the Protein Modifications in Plasma during SARS-CoV-2 Infection.Int J Mol Sci. 2023 Sep 14;24(18):14109. doi: 10.3390/ijms241814109. Int J Mol Sci. 2023. PMID: 37762413 Free PMC article.
-
Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity.J Inflamm Res. 2023 May 22;16:2189-2207. doi: 10.2147/JIR.S410140. eCollection 2023. J Inflamm Res. 2023. PMID: 37250106 Free PMC article.
-
Licochalcone A Exerts Anti-Cancer Activity by Inhibiting STAT3 in SKOV3 Human Ovarian Cancer Cells.Biomedicines. 2023 Apr 24;11(5):1264. doi: 10.3390/biomedicines11051264. Biomedicines. 2023. PMID: 37238935 Free PMC article.
References
-
- Akira S, et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 1994;77:63–71. - PubMed
-
- Zhong Z, Wen Z, Darnell JE., Jr Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95–98. - PubMed
-
- Yu CL, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science. 1995;269:81–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous